Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment.
We present a patient with breast cancer who developed papillary serous adenocarcinoma of the ovary after 13 years of tamoxifen use. The possible association is explored and the literature is reviewed.
Seoud
M
M
Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Lebanon.
Salem
Z
Z
Shamseddine
A
A
Khabbaz
A
A
Zaatari
G
G
Khalil
A
A
D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D018283:Cystadenocarcinoma, Papillary / Q000139:chemically induced*; D004965:Estrogen Antagonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000139:chemically induced*; D013629:Tamoxifen / Q000009:adverse effects*
D004965:Estrogen Antagonists; D013629:Tamoxifen